Author: Meghan Rosen

In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health is unclear.

Daraxonrasib, which nearly doubled patients’ survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.

From special pens to earwax evaluations, a plethora of emerging diagnostics could one day be a major boon for people with the debilitating disease.

Scientist Saul Justine Newman debunks high-profile longevity research and antiaging “medicine” in a new book.

DNA can voyage along intercellular highways called tunneling nanotubes. It’s a phenomenon that could potentially spread tumor DNA to healthy cells.